1. Home
  2. DAIO vs VYNE Comparison

DAIO vs VYNE Comparison

Compare DAIO & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Data I/O Corporation

DAIO

Data I/O Corporation

HOLD

Current Price

$3.60

Market Cap

22.3M

Sector

Industrials

ML Signal

HOLD

Logo VYNE Therapeutics Inc.

VYNE

VYNE Therapeutics Inc.

HOLD

Current Price

$0.66

Market Cap

22.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAIO
VYNE
Founded
1969
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.3M
22.3M
IPO Year
1995
2017

Fundamental Metrics

Financial Performance
Metric
DAIO
VYNE
Price
$3.60
$0.66
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$5.22
N/A
AVG Volume (30 Days)
138.5K
144.2K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.33
EPS
N/A
N/A
Revenue
$21,500,000.00
N/A
Revenue This Year
$4.51
N/A
Revenue Next Year
$30.29
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.16
$0.29
52 Week High
$4.49
$1.96

Technical Indicators

Market Signals
Indicator
DAIO
VYNE
Relative Strength Index (RSI) 55.27 45.99
Support Level $2.98 $0.56
Resistance Level $4.49 $0.69
Average True Range (ATR) 0.32 0.02
MACD -0.00 -0.00
Stochastic Oscillator 39.32 49.10

Price Performance

Historical Comparison
DAIO
VYNE

About DAIO Data I/O Corporation

Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary and differentiated therapies for the treatment of immuno-inflammatory conditions. The company is also in the pre-clinical stages of research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in human. Its products include AMZEEQ, ZILXI, and FCD105.

Share on Social Networks: